Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3D72S | — |
Maladministration after the expiration date; Inappropriate Schedule of Vaccine (administration on a sixteen-month-old patient); This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-month-old male patient who received MMR (Priorix) (batch number 3D72S, expiry date 01-SEP-2025) for prophylaxis. On 09-OCT-2025, the patient received Priorix. On 09-OCT-2025, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: Maladministration after the expiration date) and inappropriate age at vaccine administration (Verbatim: Inappropriate Schedule of Vaccine (administration on a sixteen-month-old patient)). The outcome of the expired vaccine used and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date:14-OCT-2025 The reporter stated the maladministration after the expiration date of a Priorix vaccine.